Protagonist Therapeutics (PTGX) earnings

Earnings (net income) · fiscal 2025
-$130.15M

Protagonist Therapeutics (PTGX) reported net income of -$130.15M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $275.19M. Figures as of 18 Nov 2026, 09:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$130.15M
Highest on record
$275.19Mfiscal 2024
Lowest on record
-$130.15Mfiscal 2025
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Protagonist Therapeutics earnings, in more detail

Across the 12 fiscal years on record (2014–2025), the highest was $275.19M in fiscal 2024 and the lowest -$130.15M in fiscal 2025.

History · 12 fiscal years

Earnings (net income) by fiscal year

Protagonist Therapeutics earnings, year by year

Protagonist Therapeutics (PTGX) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$130.15M 147.3% down
2024$275.19M—
2023-$78.96M—
2022-$127.39M—
2021-$125.55M—
2020-$66.15M—
2019-$77.19M—
2018-$38.92M—
2017-$36.96M—
2016-$37.18M—
2015-$14.86M—
2014-$11.07M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Protagonist Therapeutics and comparable companies
CompanyEarnings (net income)Fiscal year
Praxis Precision Medicines PRAX-$303.27M2025
Twist Bioscience TWST-$130.20M2026
Protagonist Therapeutics PTGX-$130.15M2025
Krystal Biotech KRYS$204.83M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTGX

Protagonist Therapeutics, figure by figure

Protagonist Therapeutics (PTGX) overview: price, valuation and scorecardAll health care companies by market value

Protagonist Therapeutics earnings: questions and answers

What is Protagonist Therapeutics's net income?

Protagonist Therapeutics (PTGX) reported net income of -$130.15M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $275.19M.

What are the highest and lowest net income figures on record for Protagonist Therapeutics?

Across the 12 fiscal years on record (2014–2025), the highest was $275.19M in fiscal 2024 and the lowest -$130.15M in fiscal 2025.

How is Protagonist Therapeutics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For Protagonist Therapeutics it is on record here for 12 fiscal years, 2014 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Protagonist Therapeutics (PTGX) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/PTGX/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.